Literature DB >> 21899371

Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines.

Peng Xu1, Mohammad Murshid Alam, Anuj Kalsy, Richelle C Charles, Stephen B Calderwood, Firdausi Qadri, Edward T Ryan, Pavol Kováč.   

Abstract

Bacterial O-SP-core antigens can be conjugated to proteins in the same, simple way as synthetic, linker-equipped carbohydrates by applying squaric acid chemistry. Introduction of spacers (linkers) to either O-SP-core antigens or protein carriers, which is involved in commonly applied protocols, is not required. The newly developed method described here consists of preparation of a squaric acid monoester derivative of O-SP-core antigen, utilizing the amino group inherent in the core, and reaction of the monoester with the carrier protein. The intermediate monoester can be easily purified; its conjugation can be monitored by SELDI-TOF mass spectrometry and, thus, readily controlled, since the conjugation can be terminated when the desired carbohydrate-protein ratio is reached. Here, we describe production of conjugates containing the O-SP-core antigen of Vibrio cholerae O1, the major cause of cholera, a severe dehydrating diarrheal disease of humans. The resultant products are recognized by convalescent phase sera from patients recovering from cholera in Bangladesh, and anti-O-SP-core-protein responses correlate with plasma antilipopolysaccharide and vibriocidal responses, which are the primary markers of protection from cholera. The results suggest that such conjugates have potential as vaccines for cholera and other bacterial diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899371      PMCID: PMC3197769          DOI: 10.1021/bc2001984

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  29 in total

1.  Refractory periods and climate forcing in cholera dynamics.

Authors:  Katia Koelle; Xavier Rodó; Mercedes Pascual; Md Yunus; Golam Mostafa
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

2.  Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.

Authors:  R I Glass; A M Svennerholm; M R Khan; S Huda; M I Huq; J Holmgren
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

3.  Conjugating oligosaccharides to proteins by squaric acid diester chemistry: rapid monitoring of the progress of conjugation, and recovery of the unused ligand.

Authors:  A Chernyak; A Karavanov; Y Ogawa; P Kovác
Journal:  Carbohydr Res       Date:  2001-02-28       Impact factor: 2.104

4.  The cholera pandemic, still with us after half a century: time to rethink.

Authors:  Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2011-01-25

5.  Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.

Authors:  F Qadri; G Mohi; J Hossain; T Azim; A M Khan; M A Salam; R B Sack; M J Albert; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

6.  Immunochemical studies of the lipopolysaccharides of Vibrio cholerae: constitution of O specific side chain and core polysaccharide.

Authors:  S Raziuddin
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

7.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

8.  Use of diethyl squarate for the coupling of oligosaccharide amines to carrier proteins and characterization of the resulting neoglycoproteins by MALDI-TOF mass spectrometry.

Authors:  V P Kamath; P Diedrich; O Hindsgaul
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

9.  A new homobifunctional p-nitro phenyl ester coupling reagent for the preparation of neoglycoproteins.

Authors:  Xiangyang Wu; Chang-Chun Ling; David R Bundle
Journal:  Org Lett       Date:  2004-11-25       Impact factor: 6.005

10.  Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.

Authors:  Jason B Harris; Regina C LaRocque; Fahima Chowdhury; Ashraful I Khan; Tanya Logvinenko; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2008-04-09
View more
  32 in total

1.  History of Chemistry in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Authors:  Kenneth L Kirk; Kenneth A Jacobson
Journal:  Bull Hist Chem       Date:  2014-01-01

2.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

3.  Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Authors:  Taher Uddin; Amena Aktar; Peng Xu; Russell A Johnson; M Arifur Rahman; Daniel T Leung; Sadia Afrin; Aklima Akter; Mohammad Murshid Alam; Atiqur Rahman; Fahima Chowdhury; Ashraful I Khan; Taufiqur Rahman Bhuiyan; Meagan K Bufano; Rasheduzzaman Rashu; Yanan Yu; Ying Wu-Freeman; Jason B Harris; Regina C LaRocque; Richelle C Charles; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

4.  Immunogenicity characterization of genetically fused or chemically conjugated heat-stable toxin toxoids of enterotoxigenic Escherichia coli in mice and pigs.

Authors:  Hyesuk Seo; Ti Lu; Rahul M Nandre; Qiangde Duan; Weiping Zhang
Journal:  FEMS Microbiol Lett       Date:  2019-02-01       Impact factor: 2.742

5.  Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.

Authors:  Russell A Johnson; Taher Uddin; Amena Aktar; M Mohasin; Mohammad Murshid Alam; Fahima Chowdhury; Jason B Harris; Regina C LaRocque; Meagan Kelly Bufano; Yanan Yu; Ying Wu-Freeman; Daniel T Leung; David Sarracino; Bryan Krastins; Richelle C Charles; Peng Xu; Pavol Kovác; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

6.  Isolation, Purification, Characterization and Direct Conjugation of the Lipid A-Free Lipopolysaccharide of Vibrio cholerae O139.

Authors:  Peng Xu; Jana Korcová; Peter Baráth; Alžbeta Čížová; Jana Valáriková; Firdausi Qadri; Meagan Kelly; Robert D O'Connor; Edward T Ryan; Slavomír Bystrický; Pavol Kováč
Journal:  Chemistry       Date:  2019-08-20       Impact factor: 5.236

7.  Synthesis and immunogenicity of the Mycobacterium tuberculosis arabinomannan-CRM197 conjugate.

Authors:  Yunsong Chang; Xin Meng; Yaxin Li; Jianmei Liang; Tingshen Li; Demei Meng; Tao Zhu; Peng Yu
Journal:  Medchemcomm       Date:  2019-04-02       Impact factor: 3.597

8.  Application of protein typing in molecular epidemiological investigation of nosocomial infection outbreak of aminoglycoside-resistant Pseudomonas aeruginosa.

Authors:  Min Song; Min Tang; Yinghuan Ding; Zecai Wu; Chengyu Xiang; Kui Yang; Zhang Zhang; Baolin Li; Zhenghua Deng; Jinbo Liu
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-16       Impact factor: 4.223

9.  Conjugation of carbohydrates to proteins using di(triethylene glycol monomethyl ether) squaric acid ester revisited.

Authors:  Peng Xu; Michael N Trinh; Pavol Kováč
Journal:  Carbohydr Res       Date:  2017-11-07       Impact factor: 2.104

10.  O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.

Authors:  Amena Aktar; M Arifur Rahman; Sadia Afrin; M Omar Faruk; Taher Uddin; Aklima Akter; M Israk Nur Sami; Tahirah Yasmin; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Regina C LaRocque; Richelle C Charles; Taufiqur Rahman Bhuiyan; Anjali Mandlik; Meagan Kelly; Pavol Kováč; Peng Xu; Stephen B Calderwood; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2016-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.